IP Verse

Wichmann patent opposition analysis

The comprehensive analysis of Wichmann opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Wichmann

Stay updated with the latest patent oppositions filed by Wichmann

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3752180
Methods For Treating Cancer With Anti-Pd-1 AntibodiesMERCK SHARP & DOHME LLCAug 17, 2026WUESTHOFF & WUESTHOFF
EP3858859
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL-MYERS SQUIBB COMPANYMar 12, 2026WUESTHOFF & WUESTHOFF
EP3359572
Method For Treating Multiple SclerosisF. HOFFMANN-LA ROCHE AGAug 26, 2025POLPHARMA BIOLOGICS
EP3509637
Methods Of Using A Bispecific Antibody That Recognizes Coagulation Factor Ix And/Or Activated Coagulation Factor Ix And Coagulation Factor X And/Or Activated Coagulation Factor XCHUGAI SEIYAKU KABUSHIKI KAISHAAug 25, 2025WUESTHOFF & WUESTHOFF
EP4152004
Assay For Jc Virus AntibodiesBIOGEN MA INC.Aug 19, 2025POLPHARMA BIOLOGICS
EP3689365
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISK A/SAug 6, 2025WUESTHOFF & WUESTHOFF
EP3638243
Methods For Treating Myeloproliferative Neoplasm-Associated Myelofibrosis And AnemiaCELGENE CORPORATIONMay 5, 2025WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB
EP3747464
 - Mar 25, 2025POLPHARMA BIOLOGICS
EP3490582
Methods And Compositions For Treating MyelofibrosisACCELERON PHARMA INC.Mar 10, 2025WUESTHOFF & WUESTHOFF
EP3529360
Methods For Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (Pcsk9) Protein ReductionNOVARTIS AGJan 15, 2025POLPHARMA

Top clients of Wichmann

Top companies who are the clients of Wichmann

CompanyTotal
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB23
WUESTHOFF & WUESTHOFF13
POLPHARMA BIOLOGICS9
POLPHARMA3
PHARMACEUTICAL WORKS POLPHARMA SA3
COOKE3
NOVOZYMES2
RIGONTEC GMBH2
SANDOZ1
MERCK SHARP & DOHME1